Monkeypox Vaccine: Following the Coronavirus, Monkeypox cases are currently rapidly rising in several nations throughout the world. In India as well, the threat posed by this virus has started to grow.

In the midst of all of this, the debate over the Monkeypox vaccine has begun to pick up steam. In this episode, Tuesday's discussion between Serum Institute of India CEO Adar Poonawalla and Union Health Minister Mansukh Mandaviya takes place.

Monkeypox Vaccine: What did Adar Poonawalla say about the vaccine?

After meeting with Union Health Minister Mansukh Mandaviya, CEO of Serum Institute of India Adar Poonawalla said, "My meeting was good as always."

All vaccination preparations are under progress due to the rising threat of monkeypox.

The CEO of Serum Institute of India Adar Poonawalla said that we are researching the vaccine for monkeypox.

However, the possibility of monkeypox taking the form of an epidemic like the covid-19 is less. He claimed that India had also received reports of monkeypox infections.

However, the vaccine is being developed and will beavailable in a few months.

Monkeypox Vaccine: Danish company has made Monkeypox vaccine

In the midst of all of this, information has emerged that a Danish company has created a monkeypox vaccine. However, there is currently no information accessible regarding its Affiliate statistics.

However, the European Union has given its approval for this vaccine. Following this, the debate over this vaccine grew more heated everywhere.

Bavarian Nordic is the brand name of the vaccine manufacturer. Investigation into the efficacy data of this vaccine is anticipated to begin soon.